206 Users Online
Cannabidiol Supplements Market Segmented By Product Type such as Food and beverages, Medicines and therapeutics, Skincare products with Application such as Epilepsy, Multiple sclerosis, Bipolar disorder, Schizophrenia, Parkinson disease
Cannabidiol are obtained from hemp plant and are known for their antipsychotic properties. Cannabidiol are widely used in the treatment of neuropsychiatric disorders such as epilepsy, schizophrenia, etc. Cannabinoids are also used in treating anxiety, insomnia, and depression. There is an increasing demand of cannabidiol globally due to its several benefits and applications.
Cannabidiol are used in cosmetics, food and beverages, and therapeutic medicines. Market players are trying to expand the therapeutic application of cannabidiol thus creating more opportunity and scope for the growth of the cannabidiol supplements market in the future. Epidiolex is the first FDA approved cannabidiol drug in the market.
Rising prevalence of diseases like epilepsy, schizophrenia are the major factors driving growth of the cannabidiol supplements market. Increasing use of cannabidiol in skincare products is further anticipated to surge the growth of the cannabidiol supplements market.
The cosmetics skincare products infused with cannabidiol improves anti-aging properties of the cosmetics and helps in natural healing of skin. Growing demand of cannabidiol in pharmaceutical products is supporting the growth of the cannabidiol supplements market. Increasing legalization of cannabidiol for medicinal use is further expected to aid in the growth of the cannabidiol supplements market. The increasing demand of cannabidiol in food and beverages industries as a supplement is further aiding the cannabidiol supplements market growth.
Intensive research and development activities to expand the therapeutic applications of cannabidiol is anticipated to support the growth of the cannabidiol supplements market. The presence of huge number of market players are further anticipated to boost the growth of the cannabidiol supplements market. However there are several side-effects associated with the usage of cannabidiol such as diarrhea, headaches, fatigue etc., which in turn hamper the growth of the cannabidiol supplements market.
|Based on Product Type
|Based on Application
|Based on Form
|Based on Distribution Channel
The North America is accounted for significant market share in terms of revenue and is expected to dominate the cannabidiol supplements market over the forecast period. This is attributed to the rising prevalence of epilepsy and schizophrenia patient. Also, intensive research and development activities is further aiding in the growth of the cannabidiol supplements market.
Furthermore FDA approval of cannabidiols are further assisting the growth of the cannabidiol supplements market. Europe is accounted for second most lucrative region due to higher adoption of cannabidiol medication. Also improved healthcare facilities and FDA approval of several cannabidiol medicines in the region is further expected to drive the growth of the cannabidiol supplements market in the region.
The Asia Pacific is expected to register prominent growth in the near future, owing to the increasing patients of schizophrenia and rising awareness of people towards benefits of cannabidiol. The higher disposable income of the people and increasing healthcare per capita is also contributing to the cannabidiol supplements market growth.
The major key players operating in the cannabidiol supplements market are Greenwich Biosciences, Inc., Endoca, C V Sciences, Isodiol International, Global cannabinoids, Folium Biosciences, HempMeds, Stock CBD supplements, Medical Marijuana, Inc, Elixinol, and Pharmahemp D.o.o.